CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy VP, Sales and Marketing bought 2,000 shares at an average $2.33 ($4,651)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy VP, Sales and Marketing bought 10,000 shares at an average $3.18 ($31,750)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Former Director acquired 11,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 36,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 34,000 shares (grant or award)
- 4 Grant or award Director acquired 38,000 shares (grant or award)
- 4 Grant or award Director acquired 39,500 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4/A Derivatives Options or other derivatives
Page 19 of 28 · 551 filings